T. Rowe Price Investment Management, Inc. Kura Oncology, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $2.34 Million - $3.19 Million	-218,533 Reduced 8.19%	2,450,031 $30 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $1.08 Million - $1.63 Million	96,395 Added 3.75%	2,668,564 $33.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $30.9 Million - $50 Million	2,572,169 New	2,572,169 $35.1 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.